TAS2R14 and ovarian carcinoma: However, conflicting data have been published demonstrating that noscapine (NOS), an agonist of the human TAS2R14, can induce apoptosis in human ovarian cancer cells not only through its documented alteration of microtubule assembly dynamics [53], but also through activation of TAS2R14 [40].